A randomised, double blinded, active controlled study evaluating the efficacy and safety of romiplostim treatment of thrombocytopenia in subjects with low or intermediate 1 risk myelodysplastic syndrome (MDS)

2.50
Hdl Handle:
http://hdl.handle.net/10147/136497
Title:
A randomised, double blinded, active controlled study evaluating the efficacy and safety of romiplostim treatment of thrombocytopenia in subjects with low or intermediate 1 risk myelodysplastic syndrome (MDS)
Issue Date:
21-Jul-2011
URI:
http://hdl.handle.net/10147/136497
Keywords:
BLOOD AND IMMUNE DISORDER
Ethical Approval:
N/A
Planned completion Date:
2011-12
Start Date:
2009-01

Full metadata record

DC FieldValue Language
dc.date.accessioned2011-07-21T10:00:13Z-
dc.date.available2011-07-21T10:00:13Z-
dc.date.issued2011-07-21T10:00:13Z-
dc.identifier.urihttp://hdl.handle.net/10147/136497-
dc.subjectBLOOD AND IMMUNE DISORDERen
dc.titleA randomised, double blinded, active controlled study evaluating the efficacy and safety of romiplostim treatment of thrombocytopenia in subjects with low or intermediate 1 risk myelodysplastic syndrome (MDS)en
dc.type.qualificationlevelDoctoralen
cr.approval.ethicalN/Aen
cr.date.planned2011-12-
cr.date.start2009-01-
dc.description.provinceLeinster-
All Items in Lenus,the Irish health repository are protected by copyright, with all rights reserved, unless otherwise indicated.